Akt mediates an angiogenic switch in transformed keratinocytes

Carcinogenesis

Volumn 25, Issue 7, 2004, Pages 1137-1147

  Segrelles, Carmen ^a   Ruiz, Sergio ^a   Santos, Mirentxu ^a   Martínez Palacio, Jesús ^a   Lara, M Fernanda ^a   Paramio, Jesús M ^a  

^a CIEMAT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GELATINASE A; GELATINASE B; INITIATION FACTOR 4E; MESSENGER RNA; PROTEIN KINASE B; RAS PROTEIN; S6 KINASE; THROMBOSPONDIN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CELL; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SKIN CARCINOGENESIS; SUBCUTANEOUS TISSUE TUMOR;

ANIMALS; CELL DIFFERENTIATION; KERATINOCYTES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SKIN NEOPLASMS; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3242806108     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh132     Document Type: Review

References (88)

1. Slaga,T.J., Budunova,I.V., Gimenez-Conti,I.B. and Aldaz,C.M. (1996) The mouse skin carcinogenesis model. J. Invest. Dermatol. Symp. Proc., 1, 151-156.
2. Yuspa,S.H., Dlugosz,A.A., Denning,M.F. and Glick,A.B. (1996) Multistage carcinogenesis in the skin. J. Invest. Dermatol. Symp. Proc., 1, 147-150.
3. Segrelles,C., Ruiz,S., Perez,P. et al. (2002) Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene, 21, 53-64.
4. Suzuki,A., Itami,S., Ohishi,M. et al. (2003) Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res., 63, 674-681.
5. Santos,M., Paramio,J.M., Bravo,A., Ramirez,A. and Jorcano,J.L. (2002) The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis. J. Biol. Chem., 277, 19122-19130.
6. Paramio,J.M., Segrelles,C., Ruiz,S. and Jorcano,J.L. (2001) Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest. Mol. Cell. Biol., 21, 7449-7459.
7. Santos,M., Ballestin,C., Garcia-Martin,R. and Jorcano,J.L. (1997) Delays in malignant tumor development in transgenic mice by forced epidermal keratin 10 expression in mouse skin carcinomas. Mol. Carcinog., 20, 3-9.
8. Nicholson,K.M. and Anderson,N.G. (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal., 14, 381-395.
9. Brazil,D.P. and Hemmings,B.A. (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci., 26, 657-664.
10. Hanahan,D. and Folkman,J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364.
11. Conti,C.J. (2002) Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. Oncologist, 7, 4-11.
12. Ferrara,N. (2002) VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer, 2, 795-803.
13. Harmey,J.H. and Bouchier-Hayes,D. (2002) Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy. Bioessays, 24, 280-283.
14. Bolontrade,M.F., Stern,M.C., Binder,R.L., Zenklusen,J.C., Gimenez-Conti,I.B. and Conti,C.J. (1998) Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis, 19, 2107-2113.
15. Larcher,F., Robles,A.I., Duran,H., Murillas,R., Quintanilla,M., Cano,A., Conti,C.J. and Jorcano,J.L. (1996) Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res., 56, 5391-5396.
16. Larcher,F., Murillas,R., Bolontrade,M., Conti,C.J. and Jorcano,J.L. (1998) VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene, 17, 303-311.
17. Casanova,M.L., Larcher,F., Casanova,B., Murillas,R., Fernandez-Acenero,M.J., Villanueva,C., Martinez-Palacio,J., Ullrich,A., Conti,C.J. and Jorcano,J.L. (2002) A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res., 62, 3402-3407.
18. Park,B.K., Zeng,X. and Glazer,R.I. (2001) Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res., 61, 7647-7653.
19. Papathoma,A.S., Zoumpourlis,V., Balmain,A. and Pintzas,A. (2001) Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis. Mol. Carcinog., 31, 74-82.
20. Bergers,G., Brekken,R., McMahon,G. et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell. Biol., 2, 737-744.
21. Bleuel,K., Popp,S., Fusenig,N.E., Stanbridge,E.J. and Boukamp,P. (1999) Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc. Natl Acad. Sci. USA, 96, 2065-2070.
22. Hawighorst,T., Oura,H., Streit,M., Janes,L., Nguyen,L., Brown,L.F., Oliver,G., Jackson,D.G. and Detmar,M. (2002) Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene, 21, 7945-7956.
23. Streit,M., Velasco,P., Brown,L.F., Skobe,M., Richard,L., Riccardi,L., Lawler,J. and Detmar,M. (1999) Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am. J. Pathol., 155, 441-452.
24. Hawighorst,T., Velasco,P., Streit,M., Hong,Y.K., Kyriakides,T.R., Brown,L.F., Bornstein,P. and Detmar,M. (2001) Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J., 20, 2631-2640.
25. Shiojima,I. and Walsh,K. (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res., 90, 1243-1250.
26. Zundel,W., Schindler,C., Haas-Kogan,D. et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev., 14, 391-396.
27. Huang,J. and Kontos,C.D. (2002) PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J. Biol. Chem., 277, 10760-10766.
28. Jiang,B.H., Zheng,J.Z., Aoki,M. and Vogt,P.K. (2000) Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl Acad. Sci. USA, 97, 1749-1753.
29. Wen,S., Stolarov,J., Myers,M.P., Su,J.D., Wigler,M.H., Tonks,N.K. and Durden,D.L. (2001) PTEN controls tumor-induced angiogenesis. Proc. Natl Acad. Sci. USA, 98, 4622-4627.
30. Yuspa,S.H., Morgan,D., Lichti,U., Spangler,E.F., Michael,D., Kilkenny,A. and Hennings,H. (1986) Cultivation and characterization of cells derived from mouse skin papillomas induced by an initiation-promotion protocol. Carcinogenesis, 7, 949-958.
31. Paramio,J.M., Segrelles,C., Ruiz,S., Martin-Caballero,J., Page,A., Martinez,J., Serrano,M. and Jorcano,J.L. (2001) The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence and carcinogenesis. J. Biol. Chem., 276, 44203-44211.
32. Roop,D.R., Lowy,D.R., Tambourin,P.E., Strickland,J., Harper,J.R., Balaschak,M., Spangler,E.F. and Yuspa,S.H. (1986) An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature, 323, 822-824.
33. Forsythe,J.A., Jiang,B.H., Iyer,N.V., Agani,F., Leung,S.W., Koos,R.D. and Semenza,G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16, 4604-4613.
34. Santos,M., Perez,P., Segrelles,C., Ruiz,S., Jorcano,J.L. and Paramio,J.M. (2003) Impaired NF-kappa B activation and increased production of tumor necrosis factor alpha in transgenic mice expressing keratin K10 in the basal layer of the epidermis. J. Biol. Chem., 278, 13422-13430.
35. Srinivas,V., Leshchinsky,I., Sang,N., King,M.P., Minchenko,A. and Caro,J. (2001) Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J. Biol. Chem., 276, 21995-21998.
36. Arsham,A.M., Plas,D.R., Thompson,C.B. and Simon,M.C. (2002) Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem., 277, 15162-15170.
37. Weng,Q.P., Kozlowski,M., Belham,C., Zhang,A., Comb,M.J. and Avruch,J. (1998) Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J. Biol. Chem., 273, 16621-16629.
38. Pullen,N. and Thomas,G. (1997) The modular phosphorylation and activation of p70s6k. FEBS Lett., 410, 78-82.
39. Aoki,M., Blazek,E. and Vogt,P.K. (2001) A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc. Natl Acad. Sci. USA, 98, 136-141.
40. Margulies,I.M., Hoyhtya,M., Evans,C., Stracke,M.L., Liotta,L.A. and Stetler-Stevenson,W.G. (1992) Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 1, 467-474.
41. Nikkari,S.T., Hoyhtya,M., Isola,J. and Nikkari,T. (1996) Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am. J. Pathol., 149, 1427-1433.
42. Boocock,C.A., Charnock-Jones,D.S., Sharkey,A.M., McLaren,J., Barker,P.J., Wright,K.A., Twentyman,P.R. and Smith,S.K. (1995) Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J. Natl Cancer Inst., 87, 506-516.
43. Dixit,V.M., Galvin,N.J., O'Rourke,K.M. and Frazier,W.A. (1986) Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. J. Biol. Chem., 261, 1962-1968.
44. Leis,H., Segrelles,C., Ruiz,S., Santos,M. and Paramio,J.M. (2002) Expression, localization and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis. Mol. Carcinog., 35, 180-185.
45. Huang,J., Frischer,J.S., Serur,A. et al. (2003) Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc. Natl Acad. Sci. USA, 100, 7785-7790.
46. Hungerford,J.E., Owens,G.K., Argraves,W.S. and Little,C.D. (1996) Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev. Biol., 178, 375-392.
47. von Marschall,Z., Cramer,T., Hocker,M., Finkenzeller,G., Wiedenmann,B. and Rosewicz,S. (2001) Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut, 48, 87-96.
48. Nabors,L.B., Gillespie,G.Y., Harkins,L. and King,P.H. (2001) HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res., 61, 2154-2161.
49. Mazure,N.M., Chen,E.Y., Laderoute,K.R. and Giaccia,A.J. (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood, 90, 3322-3331.
50. Rak,J., Mitsuhashi,Y., Sheehan,C., Tamir,A., Viloria-Petit,A., Filmus,J., Mansour,S.J., Ahn,N.G. and Kerbel,R.S. (2000) Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res., 60, 490-498.
51. Xiong,S., Grijalva,R., Zhang,L., Nguyen,N.T., Pisters,P.W., Pollock,R.E. and Yu,D. (2001) Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Cancer Res., 61, 1727-1732.
52. Dong,G., Chen,Z., Li,Z.Y., Yeh,N.T., Bancroft,C.C. and Van Waes,C. (2001) Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res., 61, 5911-5918.
53. Campbell,S.L., Khosravi-Far,R., Rossman,K.L., Clark,G.J. and Der,C.J. (1998) Increasing complexity of Ras signaling. Oncogene, 17, 1395-1413.
54. Vojtek,A.B. and Der,C.J. (1998) Increasing complexity of the Ras signaling pathway. J. Biol. Chem., 273, 19925-19928.
55. Kevil,C.G., De Benedetti,A., Payne,D.K., Coe,L.L., Laroux,F.S. and Alexander,J.S. (1996) Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int. J. Cancer, 65, 785-790.
56. Akiri,G., Nahari,D., Finkelstein,Y., Le,S.Y., Elroy-Stein,O. and Levi,B.Z. (1998) Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene, 17, 227-236.
57. Stein,I., Itin,A., Einat,P., Skaliter,R., Grossman,Z. and Keshet,E. (1998) Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol., 18, 3112-3119.
58. Chung,J., Bachelder,R.E., Lipscomb,E.A., Shaw,L.M. and Mercurio,A.M. (2002) Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J. Cell. Biol., 158, 165-174.
59. Shima,D.T., Kuroki,M., Deutsch,U., Ng,Y.S., Adamis,A.P. and D'Amore,P.A. (1996) The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem., 271, 3877-3883.
60. Huez,I., Bornes,S., Bresson,D., Creancier,L. and Prats,H. (2001) New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol. Endocrinol., 15, 2197-2210.
61. Huez,I., Creancier,L., Audigier,S., Gensac,M.C., Prats,A.C. and Prats,H. (1998) Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA. Mol. Cell. Biol., 18, 6178-6190.
62. Miller,D.L., Dibbens,J.A., Damert,A., Risau,W., Vadas,M.A. and Goodall,G.J. (1998) The vascular endothelial growth factor mRNA contains an internal ribosome entry site. FEBS Lett., 434, 417-420.
63. Scott,P.A., Smith,K., Poulsom,R., De Benedetti,A., Bicknell,R. and Harris,A.L. (1998) Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. Br. J. Cancer, 77, 2120-2128.
64. Graff,J.R. and Zimmer,S.G. (2003) Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin. Exp. Metastasis, 20, 265-273.
65. Gingras,A.C., Kennedy,S.G., O'Leary,M.A., Sonenberg,N. and Hay,N. (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Dev., 12, 502-513.
66. Goncharova,E.A., Goncharov,D.A., Eszterhas,A. et al. (2002) Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem., 277, 30958-30967.
67. Shi,Y., Hsu,J.H., Hu,L., Gera,J. and Lichtenstein,A. (2002) Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6. J. Biol. Chem., 277, 15712-15720.
68. Leis,H., Page,A., Ramirez,A., Bravo,A., Segrelles,C., Paramio,J., Barettino,D., Jorcano,J.L. and Perez,P. (2004) Glucocorticoid receptor counteracts tumorigenic activity of Akt in skin through interference with the phosphatidylinositol 3-kinase signaling pathway. Mol. Endocrinol., 18, 303-311.
69. Budunova,I.V., Kowalczyk,D., Perez,P., Yao,Y.J., Jorcano,J.L. and Slaga,T.J. (2003) Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis. Oncogene, 22, 3279-3287.
70. Neshat,M.S., Mellinghoff,I.K., Tran,C., Stiles,B., Thomas,G., Petersen,R., Frost,P., Gibbons,J.J., Wu,H. and Sawyers,C.L. (2001) Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl Acad. Sci. USA, 98, 10314-10319.
71. Podsypanina,K., Lee,R.T., Politis,C. et al. (2001) An inhibitor of mTOR reduces neoplasia and normalizes p70/56 kinase activity in Pten+/- mice. Proc. Natl Acad. Sci. USA, 98, 10320-10325.
72. Sekulic,A., Hudson,C.C., Homme,J.L., Yin,P., Otterness,D.M., Karnitz,L.M. and Abraham,R.T. (2000) A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res., 60, 3504-3513.
73. Raught,B. and Gingras,A.C. (1999) eIF4E activity is regulated at multiple levels. Int. J. Biochem. Cell Biol., 31, 43-57.
74. Nomura,M., He,Z., Koyama,I., Ma,W.Y., Miyamoto,K. and Dong,Z. (2003) Involvement of the Akt/mTOR pathway on EGF-induced cell transformation. Mol. Carcinog., 38, 25-32.
75. Zhong,H., Chiles,K., Feldser,D., Laughner,E., Hanrahan,C., Georgescu,M.M., Simons,J.W. and Semenza,G.L. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res., 60, 1541-1545.
76. Jiang,B.H., Jiang,G., Zheng,J.Z., Lu,Z., Hunter,T. and Vogt,P.K. (2001) Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ., 12, 363-369.
77. Treins,C., Giorgetti-Peraldi,S., Murdaca,J., Semenza,G.L. and Van Obberghen,E. (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem., 277, 27975-27981.
78. Blancher,C., Moore,J.W., Robertson,N. and Harris,A.L. (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res., 61, 7349-7355.
79. Alvarez-Tejado,M., Alfranca,A., Aragones,J., Vara,A., Landazuri,M.O. and del Peso,L. (2002) Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem., 277, 13508-13517.
80. Coussens,L.M., Tinkle,C.L., Hanahan,D. and Werb,Z. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 103, 481-490.
81. Silletti,S., Kessler,T., Goldberg,J., Boger,D.L. and Cheresh,D.A. (2001) Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc. Natl Acad. Sci. USA, 98, 119-124.
82. Pfeifer,A., Kessler,T., Silletti,S., Cheresh,D.A. and Verma,I.M. (2000) Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. Proc. Natl Acad. Sci. USA, 97, 12227-12232.
83. Coussens,L.M., Raymond,W.W., Bergers,G., Laig-Webster,M., Behrendtsen,O., Werb,Z., Caughey,G.H. and Hanahan,D. (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev., 13, 1382-1397.
84. Kubiatowski,T., Jang,T., Lachyankar,M.B., Salmonsen,R., Nabi,R.R., Quesenberry,P.J., Litofsky,N.S., Ross,A.H. and Recht,L.D. (2001) Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J. Neurosurg., 95, 480-488.
85. Kim,D., Kim,S., Koh,H., Yoon,S.O., Chung,A.S., Cho,K.S. and Chung,J. (2001) Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J., 15, 1953-1962.
86. Thant,A.A., Nawa,A., Kikkawa,F., Ichigotani,Y., Zhang,Y., Sein,T.T., Amin,A.R. and Hamaguchi,M. (2000) Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin. Exp. Metastasis, 18, 423-428.
87. Watnick,R.S., Cheng,Y.N., Rangarajan,A., Ince,T.A. and Weinberg,R.A. (2003) Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell, 3, 219-231.
88. Vu,T.H., Shipley,J.M., Bergers,G., Berger,J.E., Helms,J.A., Hanahan,D., Shapiro,S.D., Senior,R.M. and Werb,Z. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93, 411-422.